Laura del Llano Lemus
Psychiatric/Mental Health · Fort Lauderdale, FLNPI 1437866852
Payments from drug & device makers
Across 252 payments — averaging $19.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- Neurocrine Biosciences, Inc.$1K
- Vanda Pharmaceuticals Inc.$606
- Alkermes, Inc.$426
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$320
- Johnson & Johnson$285
- plus $871 from 11 others
What the payments were for
- Food & beverage$4,993100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 94 | $1,294 |
| Neurocrine Biosciences, Inc. | 50 | $1,191 |
| Vanda Pharmaceuticals Inc. | 24 | $606 |
| Alkermes, Inc. | 19 | $426 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $320 |
| Johnson & Johnson | 13 | $285 |
| E.r. Squibb & Sons, L.L.C. | 6 | $236 |
| AbbVie | 11 | $193 |
| Otsuka America Pharmaceutical, Inc. | 8 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $100 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Lundbeck LLC | 1 | $30 |
| Indivior Inc. | 1 | $26 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
| Almatica Pharma LLC | 1 | $18 |
| Neos Therapeutics, LP | 1 | $16 |
| Corium, LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COBENFY$125
How this compares
$4,993 in reported general payments places this provider in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 12 | $7,905 |
| Clozapine | 28 | $2,038 |
| Olanzapine OdtOlanzapine | 21 | $1,490 |
| Trazodone Hcl | 45 | $886 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 22 | $472 |
| Mirtazapine | 30 | $449 |
| Hydroxyzine Pamoate | 29 | $339 |
| Lamotrigine | 18 | $329 |
| Divalproex Sodium ErDivalproex Sodium | 15 | $324 |
| Benztropine Mesylate | 21 | $262 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $259 |
| Quetiapine Fumarate | 31 | $255 |
| Alprazolam | 16 | $181 |
| Fluoxetine Hcl | 20 | $142 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Fort Lauderdale
- Marcia BinionFort Lauderdale$13K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.